Vitamin D is a key factor in maintaining musculoskeletal health as it helps absorb calcium and phosphorus, which are necessary for the formation and strengthening of bone tissue. However, the role of vitamin D is not limited to this. Research has shown that vitamin D also plays an important role in the functioning of the immune system, regulating inflammation, and reducing the risk of developing cardiovascular diseases, diabetes, autoimmune diseases and cancer. Modern pharmaceutical technologies strive to develop vitamin D3 delivery systems that are not only more resistant to oxidative or photolytic degradation during shelf life, but are also better absorbed and have higher bioavailability. One such technology is the use of colloids. A colloid is typically a two-phase system consisting of continuous and dispersed phases. The dispersed phase particle size is typically between 0,001 and 1 micrometer. Most colloidal products are formulated to remain stable for a certain shelf life. These suspensions can be formulated in such a way that the particles remain suspended without settling to the bottom. With this approach, vitamin D3 can be more stable and bioavailable, as well as more effective.
Read full abstract